HB 1292 (2026)
Expand Right to Try and regulate stem cell therapies
This bill is still active.
Last updated 2026-01-29 1:34 pm
Summary:
Expands the "Right to Try" act to include patients with qualifying severe illnesses and establishes regulations for the use of regenerative stem cell therapies.
Status:
The data you see here is pulled daily from official government databases. The bill summary is created by Citizens Count staff. Learn more about our methodology for summarizing and updating bills. Visit the official New Hampshire government website for a deep-dive on this bill.
Browse related articles and bills:
